The FDA’s approval count last year was in line with recent trends, despite the continued impact of COVID-19. The agency’s Center for Drug Evaluation and Research (CDER) approved 50 novel therapeutics in 2021, down from 53 in 2020 (Fig. 1; Table 1). The 5-year average sits at 51 drugs per year. A decade ago, it was 24 drugs per year….

Para acessar a publicação na íntegra clique aqui

Fonte: Nature Reviews | DRUG DISCOVERY volume 21 | February 2022 | 83